Skip to content
LYB

LyondellBasell Industries NV

LyondellBasell Industries NV Q4 FY2024 earnings call

January 31, 2025 · fiscal period ended 2024-12

EPS · actual vs est

$0.75 / $1.27Miss -41.1%

Revenue · actual vs est

$9.50B / $9.30BBeat +2.2%
Ask about this call

Summary

Generated 2025-01-31

Management highlights

Management Statement and Operational Highlights

  • Safety: 2024 total recordable injury rate 0.13, lowest injuries in history. Six sites with 10+ years of no injuries, APS segment reduced incident rates by 39%.
  • Financial Results: 2024 earnings $6.40 per share, EBITDA $4.3 billion, cash from operations $3.8 billion, 90% cash conversion. Returned $1.9 billion to shareholders via dividends and repurchases.
  • Strategic Initiatives: Unlocked ~$1.3 billion incremental normalized EBITDA since Capital Markets Day 2023. Value Enhancement Program (VEP) exceeded expectations, divested non-core EO&D business, acquired 35% share in NATPET. CLCS business grew 65% in 2024, targeting $1B incremental EBITDA by 2030.
  • Capital Allocation: 2024 CapEx $1.8 billion, 2025 CapEx expected ~$1.9 billion, prioritizing high-return projects. Dividend increased 7% in May 2024, committed to returning 70% free cash flow to shareholders.
View in transcript ↓

Segment performance

Segment Performance

  • Olefins and Polyolefins Americas: Fourth quarter EBITDA was $496 million. Polyethylene volumes improved despite weak demand, assets operated at ~80% capacity. First quarter expected higher ethane/natural gas costs, planned maintenance, and impact from Winter Storm Enzo. In November, second investment in Cyclyx joint venture for circularity center in Texas.
  • Olefins and Polyolefins Europe, Asia and International: Fourth quarter EBITDA loss of $146 million due to weak markets, lower rates, and downtime. 2025 expected improved demand but feedstock supply constraints. European strategic review ongoing, CLCS business grew with APK acquisition and MoReTec-1 construction.
  • Refining: Fourth quarter EBITDA loss of $24 million. Shutdown activities ongoing, expected to be completed in first quarter, utilization rates ~35%.
  • Intermediates and Derivatives: Fourth quarter EBITDA $250 million. Oxyfuel margins low, PO/derivatives volumes improved slightly. Styrene margins under pressure.
  • Advanced Polymer Solutions: Fourth quarter EBITDA $15 million. Volumes pressured by automotive demand, but customer focus improved win rate. APS achieved record safety performance in 2024.
  • Technology: Fourth quarter EBITDA $108 million. Catalyst volumes moderated, licensing revenue higher. First quarter expected to decline due to moderating licensing revenue.
View in transcript ↓

Guidance

Guidance

  • 2025 CapEx expected ~$1.9 billion, prioritizing CLCS, flex capacity, and VEP projects.
  • CLCS business targets $1 billion incremental EBITDA from 2 million tons of annual volumes by 2030.
  • Anticipate modest seasonal demand improvements in first quarter, but impacted by turnarounds and winter storms. Confident in recovering demand from durable goods as macro conditions improve.
View in transcript ↓

Risks

Risks

  • Cyclical downturn in petrochemicals, structural shifts like slower global growth, higher energy costs, regulatory impacts.
  • Supply constraints in circular plastics market delaying brand owner targets.
  • Impact of tariffs on affordability and global trade. Unplanned downtime and maintenance affecting operations.
View in transcript ↓

Q&A highlights

Question and Answer

Q: How much CapEx expected to reach 2 million-ton circular plastics?

A: Around 20% of total CapEx, with MoReTec-1 in Germany starting 2026, MoReTec-2 in Houston in progress.

Q: Dividend increases in 2025?

A: Confident due to strong cash flow generation, Board to decide in May.

Q: Capacity rationalization in Europe?

A: Ongoing, making progress in strategic assessments, seeing slowdown in license demand.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.75$1.27-41.1%$1.26
Revenue$9.50B$9.30B+2.2%$10.63B

Transcript

January 31, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.